HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2011 | 341 | 402 | 84.8% | |
HF 4 | 2012 | 355 | 414 | 85.8% | |
HF 4 | 2013 | 420 | 472 | 89.0% | |
HF004 | 2014 | 395 | 420 | 94.0% | |
HF004 | 2015 | 439 | 463 | 94.8% | |
HF004 | 2016 | 456 | 474 | 96.2% | |
HF004 | 2017 | 468 | 488 | 95.9% | |
HF004 | 2018 | 493 | 520 | 94.8% | |
HF004 | 2019 | 507 | 525 | 96.6% |